LJN Newsletters

A series of three verdicts for plaintiffs, the most recent in December 2015, may present significant litigation issues for Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals. The suits were all based upon claims that the manufacturer failed to provide adequate warnings regarding Risperdal gynecomastia ' a condition that involves abnormally enlarged male breast tissue, especially among adolescent boys.

The Equipment Leasing & Finance Foundation (ELFA) has released its Q2 update to the 2016 Equipment Leasing & Finance U.S. Economic Outlook, which lowered its yearly equipment and software investment forecast to 2.7%, down from 4.4% growth forecast in its 2016 Annual Outlook released in December 2015.

Law firms, companies and other entities need to be on guard for an increasingly frequent, sophisticated online fraud that uses "spoofed" e-mails.

'Broadband Internet access service" (BIAS) is the essential conduit for the conduct of our daily personal and private lives, without which all Internet activity comes to a stop. Because BIAS is largely invisible, Rarely do we consider that ISPs that provide BIAS to consumers have extraordinarily broad access "to very sensitive and very personal information." The FCC has adopted a NPRM that proposes to establish privacy guidelines applicable to ISPs.

Must a board consent to an assignment based on the financial strength of a non-resident co-owner when the resident co-owner does not have assets or income sufficient to maintain the apartment? Comment and analysis of a case involving this question.

While partnership abroad may be essential to business success, it creates significant risk under the FCPA the government's primary weapon against bribery of foreign officials. Recent FCPA prosecutions by the DOJ and the SEC illustrate the risks for companies that fail to adequately vet and monitor third-party intermediaries.

A series of three verdicts for plaintiffs, the most recent occurring in December 2015, may present significant litigation issues for Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals.

The "one-percenters" that we are hearing so much about in this year's primary election campaigns also have an analogous place in current law firm economics. The rich are getting richer, and most others are struggling to hold their own.